Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
G | 0.800 | CausalMutation | CLINVAR | ||||||||||
|
|
A | 0.800 | CausalMutation | CLINVAR | ||||||||||
|
|
A | 0.800 | CausalMutation | CLINVAR | ||||||||||
|
|
T | 0.800 | CausalMutation | CLINVAR | ||||||||||
|
|
G | 0.800 | CausalMutation | CLINVAR | ||||||||||
|
|
T | 0.750 | CausalMutation | CLINVAR | Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. | 22808163 | 2012 |
|||||||
|
|
T | 0.750 | CausalMutation | CLINVAR | Activating Q209L/P mutations in GNAQ or GNA11 (GNAQ/11) are present in approximately 80% of uveal melanomas. | 22733540 | 2012 |
|||||||
|
|
C | 0.750 | CausalMutation | CLINVAR | Activating Q209L/P mutations in GNAQ or GNA11 (GNAQ/11) are present in approximately 80% of uveal melanomas. | 22733540 | 2012 |
|||||||
|
|
C | 0.750 | CausalMutation | CLINVAR | Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. | 22808163 | 2012 |
|||||||
|
|
T | 0.750 | CausalMutation | CLINVAR | Mutations in GNA11 in uveal melanoma. | 21083380 | 2010 |
|||||||
|
|
C | 0.750 | CausalMutation | CLINVAR | Mutations in GNA11 in uveal melanoma. | 21083380 | 2010 |
|||||||
|
|
C | 0.750 | CausalMutation | CLINVAR | Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. | 1328859 | 1992 |
|||||||
|
|
T | 0.750 | CausalMutation | CLINVAR | Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. | 1328859 | 1992 |
|||||||
|
|
T | 0.750 | CausalMutation | CLINVAR | GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. | 2549426 | 1989 |
|||||||
|
|
C | 0.750 | CausalMutation | CLINVAR | GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. | 2549426 | 1989 |
|||||||
|
|
T | 0.730 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
T | 0.730 | GeneticVariation | CLINVAR | Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations. | 24141786 | 2014 |
|||||||
|
|
C | 0.730 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
T | 0.730 | GeneticVariation | CLINVAR | Therapeutic implications of the emerging molecular biology of uveal melanoma. | 21444680 | 2011 |
|||||||
|
|
T | 0.700 | GeneticVariation | CLINVAR | Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. | 26619011 | 2016 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
A | 0.700 | CausalMutation | CLINVAR |